115 related articles for article (PubMed ID: 9388928)
1. [Reversal of adriamycin or vincristine resistance by tetrandrine in human cancer cells in vitro].
Ye Z; Sun A; Li L; Cao X; Ye W
Zhongguo Zhong Yao Za Zhi; 1996 Jun; 21(6):369-71, 384. PubMed ID: 9388928
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anticancer effects of tetrandrine combined with doxorubicin or vincristine in vitro.
Sun AX; Ye ZG; Li CY; Xue BY; Li LF; Cao XF; Yang Q; Dai BQ
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):69-73. PubMed ID: 10437129
[TBL] [Abstract][Full Text] [Related]
3. [Poteintation of vincristine-induced apoptosis by tetrandrine, neferine and dauricine in the human mammary MCF-7 multidrug-resistant cells].
Ye ZG; Wang JH; Sun AX; Liang AH; Xue BY; Li CY; Wang L
Yao Xue Xue Bao; 2001 Feb; 36(2):96-9. PubMed ID: 12579872
[TBL] [Abstract][Full Text] [Related]
4. [Reversal effect of Ys-96, a bisbenzylisoquinoline, on adriamycin or vincristine resistance in human cancer cells in vitro].
Ye Z; Sun A; Li C; Xue B; Wang Z; Tong Y; Feng H; Liang A; Wang J; Yang Q
Zhongguo Zhong Yao Za Zhi; 1998 Jul; 23(7):427-8, inside back cover. PubMed ID: 11601355
[TBL] [Abstract][Full Text] [Related]
5. [Reversal of anti-apoptotic action by tetrandrine in human breast carcinoma multidrug-resistant MCF-7 cells].
Wang JH; Ye ZG; Sun AX; Xue BY; Liang AH; Li CY; Wang L
Zhongguo Zhong Yao Za Zhi; 2002 Jan; 27(1):46-50. PubMed ID: 12774357
[TBL] [Abstract][Full Text] [Related]
6. [Synergistic interaction between Ys-96, a bisbenzylisoquinoline compound derived from Stephania tetrandra, and adriamycin or vincristine against human cancer cell lines in vitro].
Ye Z; Sun A; Li C; Xue B; Liang A; Wang J; Wang Z; Tong Y; Feng H
Zhongguo Zhong Yao Za Zhi; 1999 Sep; 24(9):556-9, 576. PubMed ID: 12205903
[TBL] [Abstract][Full Text] [Related]
7. [A comparative study on effect of two bisbenzylisoquinolines, tetrandrine and berbamine, on reversal of multidrug resistance].
Tian H; Pan QC
Yao Xue Xue Bao; 1997 Apr; 32(4):245-50. PubMed ID: 11499024
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
Jin J; Wang FP; Wei H; Liu G
Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
[TBL] [Abstract][Full Text] [Related]
9. [Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine].
Huang YH; Zhang SH; Zhen RX; Xu XD; Zhen YS
Ai Zheng; 2004 Dec; 23(12):1599-604. PubMed ID: 15601545
[TBL] [Abstract][Full Text] [Related]
10. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
Zhu X; Sui M; Fan W
Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
[TBL] [Abstract][Full Text] [Related]
12. Reversal of doxorubicin resistance by tetrandrine in Chinese hamster ovary cell line.
He QY; Jiang B; Zhang HQ; Xue SB
Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):416-9. PubMed ID: 1300043
[TBL] [Abstract][Full Text] [Related]
13. [Reversal of resistance to adriamycin in human breast cancer cell line MCF-7/ADM by beta-elemene].
Hu J; Jin W; Yang PM
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):268-70. PubMed ID: 15312359
[TBL] [Abstract][Full Text] [Related]
14. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
15. Potential role of tetrandrine in cancer therapy.
Chen YJ
Acta Pharmacol Sin; 2002 Dec; 23(12):1102-6. PubMed ID: 12466047
[TBL] [Abstract][Full Text] [Related]
16. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
17. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells.
He QY; Meng FH; Zhang HQ
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):179-81. PubMed ID: 9772674
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
19. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
[TBL] [Abstract][Full Text] [Related]
20. [Reversing multidrug resistance of epidermoid carcinoma drug-resistant cell line KB-MRP1 by tetrandrine].
Chen XS; Bao MH; Mei XD
Ai Zheng; 2007 Aug; 26(8):846-50. PubMed ID: 17697545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
